Purpose Of Review: Ocular sarcoidosis is one of the most common causes of uveitis worldwide. The diagnosis and treatment of patients with ocular sarcoidosis remains challenging in some cases. It is important for clinicians to keep up to date with new diagnostic and treatment tools for this disease.
Recent Findings: The International Workshop on Ocular Sarcoidosis diagnostic criteria were first proposed in 2009 and revised in 2017. The new criteria contained two parts: ocular presentation and systemic investigation. The diagnostic value of liver enzymes was reduced in the new criteria, whereas the value placed of lymphopenia and the CD4/CD8 ratio in bronchoalveolar lavage fluid were increased. Despite not being included in the criteria, recent studies have also highlighted the diagnostic value of serum soluble interleukin-2 receptors. Recent ophthalmologic imaging also provides useful insights for the differential diagnosis.Many new treatments for ocular sarcoidosis have been developed in recent years. The introduction of biological immunomodulatory agents for uveitis treatment represents a big improvement. Antitumor necrosis factor-alpha antibodies, including adalimumab, have been proven to be effective for treating ocular sarcoidosis. Many studies have also suggested that other biological agents could be effective and well tolerated. Newer intravitreal dexamethasone and fluocinolone implants have been developed. Patients treated with these implants have experienced good and sustained control of their intraocular inflammation.
Summary: Diagnosis and treatment options for ocular sarcoidosis have changed over time. However, challenges still exist in some difficult patients. Future studies should focus on finding more sensitive biomarkers and developing more effective immunomodulatory treatments with longer efficacy and less side effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/ICU.0000000000000704 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successful surgical management of uveitic glaucoma in a sarcoidosis patient with cutaneous manifestations.
BMJ Case Rep
December 2024
Ophthalmology, Western Eye Hospital, Imperial College Healthcare NHS Trust, London, UK.
Sarcoidosis is a systemic granulomatous disease with variable ocular involvement. The most common ocular manifestation is uveitis, which can have potentially sight threatening complications such as glaucoma. We present the case of a man in his 30s with sarcoidosis and recurrent anterior uveitis, necessitating surgical intervention to control intraocular pressure and prevent further glaucomatous optic neuropathy progression.
View Article and Find Full Text PDFChronic Sarcoidosis: Diagnostic Difficulties and Search for New Criteria of Inflammatory Activity (A Case Report and Literature Review).
J Clin Med
November 2024
Department of Pharmacology, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russia.
Article Synopsis
- * Diagnosing sarcoidosis is challenging due to its diverse presentations and the absence of specific biomarkers, leading to complications in understanding its course and treatment.
- * The review emphasizes the need for new diagnostic criteria and recommends developing a reliable immunological or imaging marker to improve diagnosis and prognosis for patients with chronic sarcoidosis.
Prevalence and Incidence of Uveitis in Korean Patients with Sarcoidosis: A Population-Based Study.
Ocul Immunol Inflamm
November 2024
Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Article Synopsis
- Sarcoidosis is an inflammatory disease with various symptoms, and this study focuses on the incidence and prevalence of sarcoidosis-related uveitis, particularly in South Korea, to gather important epidemiological insights.
- Utilizing a nationwide health database from 2010 to 2019, the research analyzed cases of sarcoidosis and uveitis, examining incidence rates, gender differences, age of diagnosis, treatment patterns, and recurrence types among the patients.
- The findings revealed that 28.8% of sarcoidosis patients experienced uveitis, mostly recurrent, with anterior uveitis being the most common; the study underscores the necessity for regular eye examinations and tailored treatments for sarcoidosis patients in Korea due to the high
Clinico-pathologic correlation in ocular sarcoidosis.
Am J Ophthalmol Case Rep
December 2024
Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Purpose: This case describes the unique course and management of a patient with progressive, refractory multi-system sarcoidosis that initially presented with ocular and dermatologic findings.
Observations: A 47-year-old male presented with acute anterior uveitis and was found to have simultaneous inflammation of his skin at a tattoo site. Diagnosis of ocular sarcoidosis was confirmed through skin biopsy.
Pulmonary, Ocular, and Cardiac Involvement in Patients With Cutaneous Sarcoidosis of the Face and Head.
J Cutan Med Surg
November 2024
Division of Rheumatology, Department of Medicine, University of Illinois Chicago College of Medicine, Chicago, IL, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!